Multiple sclerosis is about to become a thing of the past thanks to the first ever electronic automatic injector. The injector is going to release a drug that will efficiently combat the most common form of MS and it has already been approved by the U.S. Food and Drug administration yesterday. It is safe to assume that medicine eliminated multiple sclerosis.
The drug which is delivered by the injection is called Betaseron, which has been available for approximately 22 years after it, too, was approved by the FDA. The drug tracks down the disease back to the central nervous system and it shuts it down from there.
Bayer AG has officially declared that the device, named Betaconnect, will be available as of early 2016 and will be sold with the drug as well.
There are approximately 400,000 people who have to come with MS every day in the U.S. The main concern is that 320,000 of these people are diagnosed with a form of disorder in which their symptoms are completely gone after a short period of time and they will not show up again in the following months or years. The disease is there, but it is just hidden.
Betaconnect was not the first of its kind, as Bayer developed another injector before this one. The only problem was that the device had a number of drawbacks. It could only be mechanically activated and it would make a clear sound while the patient administering it and the sound was not exactly peasant for most patients. These were Amy Ross’ identified weak spots. She is the former president of the International Organization of MS Nurses.
The new device, however, has a great number of advantages that benefit its users. It remind you every day that you need to take your medicine, it does not produce any kind of discomforting sounds. You can customize it when it comes to the depth or speed of the injection and the needle retracts automatically after the drug has been administered.
The doctors’ main concern now is the educate people on how to use these injections, especially looking at how they could affect long term use and efficiency. Many of the patients diagnosed with MS are quite young, Ross declaring that in between 50 to 60% of them are diagnosed within the ages of 20 and 30. It is important that the drug be administered in the correct way for maximum efficiency.
Photo Credits stripes.com